Scalper1 News
Top-rated drug stocks Jazz Pharmaceuticals, United Therapeutics and Questcor Pharmaceuticals all missed fourth-quarter sales estimates Tuesday, sending their shares down significantly. Jazz (JAZZ) reported revenue of $236 million, up 28% from a year earlier but about $2 million below analysts’ consensus. Profit minus one-time items also came up short at $1.72 a share, 6 cents below estimates but up 12% from the prior year. CFO Scalper1 News
Scalper1 News